Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia
- PMID: 16912980
- DOI: 10.1002/ana.20949
Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia
Abstract
Objective: The cortex of patients with cortical dysplasia contains several abnormal cell types. Among the dysplastic cells, cytomegalic neurons are known to be electrically hyperactive and may contribute to epileptic activity. In this study, we sought to identify molecular markers of cytomegalic neurons in focal or hemispheric cortical dysplasia and to determine whether the activity of the mammalian target of rapamycin (mTOR) kinase is abnormally high in these cells.
Methods: Microarray analysis of gene expression in large dysplastic cells microdissected from cortical dysplasia surgical specimens was used to identify markers of cytomegalic neurons. Immunohistochemistry and immunofluorescence analysis of cortical sections was used to validate the microarray results and to probe the activity of mTOR in cytomegalic neurons using phospho-specific antibodies directed against known mTOR targets.
Results: We demonstrate that the neurofilament heavy chain is a reliable marker of cytomegalic neurons and that targets of the mTOR kinase, such as the ribosomal protein S6, eIF4G, and Akt, are hyperphosphorylated in these dysplastic neurons.
Interpretation: We conclude that mTOR kinase hyperactivation is a molecular mechanism underlying the development of cytomegalic neurons. This finding may lead to the development of novel therapeutic approaches for childhood epilepsy associated with cortical dysplasia.
Similar articles
-
Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.Ann Neurol. 2004 Oct;56(4):510-9. doi: 10.1002/ana.20234. Ann Neurol. 2004. PMID: 15455398
-
Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.Neuroscience. 2008 Sep 22;156(1):203-15. doi: 10.1016/j.neuroscience.2008.06.073. Epub 2008 Jul 25. Neuroscience. 2008. PMID: 18706978
-
mTOR cascade activation distinguishes tubers from focal cortical dysplasia.Ann Neurol. 2004 Oct;56(4):478-87. doi: 10.1002/ana.20211. Ann Neurol. 2004. PMID: 15455405
-
Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis.Epilepsy Behav. 2006 Sep;9(2):219-35. doi: 10.1016/j.yebeh.2006.05.012. Epub 2006 Jul 27. Epilepsy Behav. 2006. PMID: 16875879 Review.
-
Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.Epilepsia. 2007;48 Suppl 5:65-73. doi: 10.1111/j.1528-1167.2007.01291.x. Epilepsia. 2007. PMID: 17910583 Review.
Cited by
-
GABAergic Interneuron and Neurotransmission Are mTOR-Dependently Disturbed in Experimental Focal Cortical Dysplasia.Mol Neurobiol. 2021 Jan;58(1):156-169. doi: 10.1007/s12035-020-02086-y. Epub 2020 Sep 10. Mol Neurobiol. 2021. PMID: 32909150
-
mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.Epilepsia. 2015 Apr;56(4):636-46. doi: 10.1111/epi.12946. Epub 2015 Mar 6. Epilepsia. 2015. PMID: 25752454 Free PMC article.
-
Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.Int J Mol Sci. 2022 Jan 25;23(3):1344. doi: 10.3390/ijms23031344. Int J Mol Sci. 2022. PMID: 35163267 Free PMC article. Review.
-
Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.Nat Commun. 2014 Aug 1;5:4563. doi: 10.1038/ncomms5563. Nat Commun. 2014. PMID: 25081057 Free PMC article.
-
Using cortical organoids to understand the pathogenesis of malformations of cortical development.Front Neurosci. 2025 Jan 15;18:1522652. doi: 10.3389/fnins.2024.1522652. eCollection 2024. Front Neurosci. 2025. PMID: 39881808 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous